Intelligent Bio Solutions Inc. (INBS)
NASDAQ: INBS · Real-Time Price · USD
1.640
-0.010 (-0.61%)
Sep 29, 2026, 2:45 PM EDT - Market open
Intelligent Bio Solutions Income Statement
Financials in millions USD. Fiscal year is July - June.
Millions USD. Fiscal year is Jul - Jun.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Operating Revenue | 4.22 | 3.05 | 3.11 | 1.26 | - |
| 4.22 | 3.05 | 3.11 | 1.26 | - | |
Revenue Growth | 38.09% | -1.90% | 147.58% | -36.54% | - |
Cost of Revenue | 2.17 | 1.81 | 1.69 | 0.93 | - |
Gross Profit | 2.05 | 1.25 | 1.43 | 0.33 | - |
Selling, General & Admin | 10.5 | 8.92 | 9.26 | 8.03 | 4.92 |
Research & Development | 3.37 | 2.4 | 1.67 | 0.51 | 3.85 |
Other Operating Expenses | -0.68 | -0.82 | -0.42 | -0.74 | -0.44 |
Operating Expenses | 14.36 | 11.71 | 11.71 | 8.76 | 8.34 |
Operating Income | -12.31 | -10.46 | -10.28 | -8.44 | -8.34 |
Interest Expense | -0.01 | -0.03 | -0.17 | -0.22 | -0.01 |
Interest & Investment Income | 0.11 | 0.1 | 0.08 | 0.01 | 0.01 |
Currency Exchange Gain (Loss) | 0.04 | -0 | -0 | -0.01 | -0 |
Other Non Operating Income (Expenses) | - | - | 0.18 | 2.15 | - |
EBT Excluding Unusual Items | -12.17 | -10.38 | -10.19 | -6.51 | -8.33 |
Impairment of Goodwill | - | - | - | -4.16 | - |
Asset Writedown | -0.3 | -0.22 | - | - | - |
Pretax Income | -12.47 | -10.6 | -10.19 | -10.66 | -8.33 |
Earnings From Continuing Operations | -12.47 | -10.6 | -10.19 | -10.66 | -8.33 |
Minority Interest in Earnings | 0.04 | 0.04 | 0.03 | 0.03 | 0.03 |
Net Income | -12.43 | -10.57 | -10.16 | -10.63 | -8.31 |
Net Income to Common | -12.43 | -10.57 | -10.16 | -10.63 | -8.31 |
Net Income Growth | - | - | - | - | - |
Shares Outstanding (Basic) | 1 | 1 | 0 | - | - |
Shares Outstanding (Diluted) | 1 | 1 | 0 | - | - |
Shares Change | 179.27% | 231.10% | - | - | - |
EPS (Basic) | -8.44 | -20.04 | -63.77 | - | - |
EPS (Diluted) | -8.44 | -20.04 | -63.80 | - | - |
EPS Growth | - | - | - | - | - |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Free Cash Flow | -12.05 | -9.91 | -9.79 | -7.88 | -3.74 |
Free Cash Flow Per Share | -8.18 | -18.79 | -61.48 | - | - |
Gross Margin | 48.63% | 40.85% | 45.81% | 25.99% | - |
Operating Margin | -292.03% | -342.64% | -330.46% | -671.24% | - |
Profit Margin | -294.91% | -346.23% | -326.40% | -845.89% | - |
Free Cash Flow Margin | -285.94% | -324.62% | -314.71% | -627.15% | - |
EBITDA | -11.15 | -9.48 | -9.31 | -7.62 | - |
EBITDA Margin | -264.42% | - | -299.15% | - | - |
D&A For EBITDA | 1.16 | 0.98 | 0.97 | 0.81 | - |
EBIT | -12.31 | -10.46 | -10.28 | -8.44 | -8.34 |
EBIT Margin | -292.03% | - | - | - | - |
Advertising Expenses | - | - | 0.73 | - | - |